TGF-β concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes

Journal of the American Society of Nephrology

Volumn 16, Issue 11, 2005, Pages 3211-3221

  Wu, Dona T ^a   Bitzer, Markus ^a   Ju, Wenjun ^b   Mundel, Peter ^b   Böttinger, Erwin P ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 2B; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; GLOMERULUS; GROWTH INHIBITION; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL CYCLE; CELL DIVISION; CYTOLOGY; FLOW CYTOMETRY; MOUSE; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CYTOKINES; FLOW CYTOMETRY; MICE; PODOCYTES; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 33644877366     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004121055     Document Type: Article

References (42)

1. Massague J: How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1: 169-178, 2000
2. Roberts AB: The ever-increasing complexity of TGF-beta signaling. Cytokine Growth Factor Rev 13: 3-5, 2002
3. Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005-3015, 2002
4. Shankland SJ, Wolf G: Cell cycle regulatory proteins in renal disease: Role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 278: F515-F529, 2000
5. Nagata M, Nakayama K, Terada Y, Hoshi S, Watanabe T: Cell cycle regulation and differentiation in the human podocyte lineage. Am J Pathol 153: 1511-1520, 1998
6. Combs HL, Shankland SJ, Setzer SV, Hudkins KL, Alpers CE: Expression of the cyclin kinase inhibitor, p27kip1, in developing and mature human kidney. Kidney Int 53: 892-896, 1998
7. Mundel P, Reiser J, Zuniga Mejia BA, Pavenstadt H, Davidson GR, Kriz W, Zeller R: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258, 1997
8. Mundel P, Heid HW, Mundel TM, Kruger M, Reiser J, Kriz W: Synaptopodin: An actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol 139: 193-204, 1997
9. Chen S, Kasama Y, Lee JS, Jim B, Marin M, Ziyadeh FN: Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes. Diabetes 53: 2939-2949, 2004
10. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, Bottinger EP: Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108: 807-816, 2001
11. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 18: 1280-1291, 1999
12. Schiffer M, Mundel P, Shaw AS, Bottinger EP: A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis. J Biol Chem 279: 37004-37012, 2004
13. Lucas C, Bald LN, Fendly BM, Mora-Worms M, Figari IS, Patzer EJ, Palladino MA: The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J Immunol 145: 1415-1422, 1990
14. Mundel P, Gilbert P, Kriz W: Podocytes in glomerulus of rat kidney express a characteristic 44 KD protein. J Histochem Cytochem 39: 1047-1056, 1991
15. Reiser J, Kriz W, Kretzler M, Mundel P: The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 11: 1-8, 2000
16. Rozen S, Skaletsky HJ: Primer3 on the WWW for general users and for biologist programmers. In: Bioinformatics Methods and Protocols: Methods in Molecular Biology, edited by Krawetz S, Misener S, Totowa, NJ, Humana Press, 2000, pp 365-386
17. Phillips AO, Steadman R, Donovan KD, Williams JD: A new antibody capture enzyme linked immunoassay specific for transforming growth factor beta 1. Int J Biochem Cell Biol 27: 207-213, 1995
18. Schiffer M, Schiffer LE, Gupta A, Shaw AS, Roberts IS, Mundel P, Bottinger EP: Inhibitory smads and TGF-beta signaling in glomerular cells. J Am Soc Nephrol 13: 2657-2666, 2002
19. Schnabel E, Anderson JM, Farquhar MG: The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium. J Cell Biol 111: 1255-1263, 1990
20. Yang YC, Piek E, Zavadil J, Liang D, Xie D, Heyer J, Pavlidis P, Kucherlapati R, Roberts AB, Bottinger EP: Hierarchical model of gene regulation by transforming growth factor beta. Proc Natl Acad Sci USA 100: 10269-10274, 2003
21. Flanders KC: Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 85: 47-64, 2004
22. Kerjaschki D: Caught flat-footed: Podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 108: 1583-1587, 2001
23. Pawlik TM, Keyomarsi K: Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59: 928-942, 2004
24. Jacotot E, Ferri KF, Kroemer G: Apoptosis and cell cycle: Distinct checkpoints with overlapping upstream control. Pathol Biol (Paris) 48: 271-279, 2000
25. Clark AT, Young RJ, Bertram JF: In vitro studies on the roles of transforming growth factor-beta 1 in rat metanephric development. Kidney Int 59: 1641-1653, 2001
26. Plisov SY, Yoshino K, Dove LF, Higinbotham KG, Rubin JS, Perantoni AO: TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis. Development 128: 1045-1057, 2001
27. Sanford LP, Ormsby I, Gittenberger-deGroot A, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T: TGF-b2 knockout mice have multiple developmental defects that are non-overlapping with other TGF-b knockout phenotypes. Development 124: 2659-2670, 1997
28. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S: Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 90: 770-774, 1993
29. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MWJ, Doetschman T: Transforming growth factor-b3 is required for secondary palate fusion. Nat Genet 11: 409-414, 1995
30. Oxburgh L, Chu GC, Michael SK, Robertson EJ: TGFbeta superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population. Development 131: 4593-4605, 2004
31. Hartner A, Hilgers KF, Bitzer M, Veelken R, Schocklmann HO: Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis. J Mol Med 81: 32-42, 2003
32. Shankland SJ, Pippin J, Pichler RH, Gordon KL, Friedman S, Gold LI, Johnson RJ, Couser WG: Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy. Kidney Int 50: 116-124, 1996
33. Bottinger EP, Bitzer M: TGF-beta signaling in renal disease. J Am Soc Nephrol 13: 2600-2610, 2002
34. Derynck R, Akhurst RJ, Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129, 2001
35. Wakefield LM, Roberts AB: TGF-beta signaling: Positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29, 2002
36. Feng XH, Lin X, Derynck R: Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J 19: 5178-5193, 2000
37. Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massague J: TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 3: 400-408, 2001
38. Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584, 2003
39. Wharton SJ, Basu SP, Ashe HL: Smad affinity can direct distinct readouts of the embryonic extracellular dpp gradient in Drosophila. Curr Biol 14: 1550-1558, 2004
40. Chacko BM, Qin BY, Tiwari A, Shi G, Lam S, Hayward LJ, De Caestecker M, Lin K: Structural basis of heteromeric smad protein assembly in TGF-beta signaling. Mol Cell 15: 813-823, 2004
41. Dennler S, Huet S, Gauthier JM: A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene 18: 1643-1648, 1999
42. Dunn NR, Koonce CH, Anderson DC, Islam A, Bikoff EK, Robertson EJ: Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile. Genes Dev 19: 152-163, 2005